FM NOVEMBER 2018 ISSUE - digital edition

This technology enables users
to fit the hearing aid settings
themselves, in real-time and
in real-world environments
without the assistance of a
healthcare professional.
In authorizing marketing
of the Bose device, the FDA
reviewed data from clinical
studies of 125 patients, which
demonstrated that outcomes
with self-fitting of the Bose
Hearing Aid are comparable
on average to those with
professional fitting of the
same device with respect to
the amount of amplification
selected, speech in noise
testing and overall benefit,
the regulatory agency said
announcing the approval.
Neuro imaging
system gets
clearance in US
The US Food and Drug
Administration has
okayed a new imaging
modality augmented reality
(AR) GLOW800 surgical
fluorescence for vascular
neurosurgery.
GLOW800 allows
surgeons to observe
cerebral anatomy in natural
colour, in combination with
ICG (Indocyanine Green),
augmented by real-time
vascular flow in a single image,
with full depth perception.
It provides the surgeon
with a complete view of
anatomy and physiology to
support crucial decisions
and actions during vascular
neurosurgery.
GLOW800 AR
fluorescence is the first of
many imaging modalities that
will be based on the GLOW
AR platform. GLOW AR
modalities can be fully
integrated into the ARveo
digital augmented reality
microscope, according to
Leica Microsystems, the
maker of the device.
Certara cloudbased
platform
to help HCPs
Certara has launched
BaseCase Portal cloudbased
platform that allows for
the rapid creation of fullycustomizable
mobile apps that
connect live to mathematical
models and algorithms, and
help HCPs optimize treatment
for individual patients.
BaseCase Portal
enables clinicians to use
Boston Scientific launches kidney stone
retrieval device
Boston Scientific Corporation has
launched LithoVue Empower Retrieval
Deployment Device, designed to be used
with the ureteroscope.
The device comes with a compatible
nitinol retrieval basket to enable urologists
to operate a ureteroscope and basket
simultaneously when retrieving kidney
stones via flexible ureteroscopy (URS).
According to Boston Scientific, until
now, urologists have traditionally relied
on another person to operate the basket
used to collect kidney stones during kidney
complex scientific models
and algorithms that were
previously only available in
research settings, to guide
therapeutic decision-making.
The platform keeps a strict
separation between the user
interface and the underlying
mathematical model. This
offers many benefits over
the old way of doing things
in which algorithms typically
were hardwired into a
website. On BaseCase Portal,
algorithms and models can be
validated and updated much
more easily.
BaseCase Portal also
features embedded version
control and release workflows,
and provides an audit trail,
allowing a new version of an
app to be uploaded as soon
as it receives the requisite
stone retrieval. Turning a two-person
stone basketing procedure into a singleperson
procedure provides greater control
for the surgeon, decreasing the risk of
miscommunication during stone basketing
without compromising time.
Retrieving kidney stones is one of
the most time-consuming steps during
ureteroscopy procedures, making this
an opportune area to improve physician
control, address communication/
coordination challenges and identify time
savings, says Boston Scientific.
84 / FUTURE MEDICINE / NOVEMBER 2018